NewswireToday (newswire) - 06/10/2008 Muenster, North Rhine-Westfalia Germany - As the first API auditor in Europe, blue inspection body GmbH has been accredited to carry out inspections of active pharmaceutical ingredient manufacturers and has been awarded the highest independence rating, type "A" Read more…

NewswireToday (newswire) - 06/09/2008 Palo Alto, CA United States - The U.S. therapeutic monoclonal antibodies market is poised for a quantum leap with the launch of a multitude of new products and vigorous expansion of therapeutic indications of existing products Read more…

NewswireToday (newswire) - 06/09/2008 Palo Alto, CA United States - Ongoing discovery of CoenzymeQ10s health benefits enhances the overall market, especially for European marketers and manufacturers who already successfully capitalized on proven cardiac benefits of the enzyme Read more…

NewswireToday (newswire) - 06/09/2008 Delhi, New Delhi India - By 2012, generics is projected to account for about 26% of total Canadian pharmaceutical market as the penetration of generics is growing rapidly in the country, says RNCOS research Read more…

NewswireToday (newswire) - 06/06/2008 San Diego, CA United States - Protech ECS announces the development and release of their first portal based program the Chemical Hazardous Inventory Classification System, also known as CHICS Read more…

NewswireToday (newswire) - 06/04/2008 Palo Alto, CA United States - Contract research organizations (CROs) hope to obtain an edge in the highly competitive healthcare industry by using technology to shorten project times, improve data quality, and thus, differentiate services Read more…

NewswireToday (newswire) - 06/02/2008 Moscow, Russia - Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia Read more…

NewswireToday (newswire) - 05/30/2008 San Diego, CA United States - Protech ECS is proud to announce the approval by the San Diego Fire Rescue Department and the San Diego City Fire Marshal?’s office to produce and submit the required FPB 500 for Biotech companies Read more…

NewswireToday (newswire) - 05/29/2008 London, United Kingdom - Report Buyer has added a new report showing that during 2008, results of major phase II studies in asthma with two different interleukin-13 antagonistic antibodies are expected, and will be decisive for the validation of a hot target Read more…

Health boards across Scotland are looking into introducing registers for all medical staff to allow them to declare if they have any links with drug companies. The news comes following fears that some of the world's pharmaceutical giants have too much influence over what drugs some doctors prescribe. NHS Greater Glasgow has told the Herald that following a consultation it hopes to have a register, which would be publicly available, in place by June. Read more…

The Medicines and Healthcare products Regulatory Agency (MHRA) has found that Napp Pharmaceuticals broke its advertising rules. A complaint was lodged about the firm's advert for the painkiller BuTrans (buprenorphine matrix patch) in the British Medical Journal in November 2005. Read more…

A pharmacy care program for elderly patients increases medication adherence according to a study appearing in JAMA. Read more…

FDA informs public of nationwide recall of 500mg strength store-brand acetaminophen caplets. Read more…

Dr Sami Timimi gives a lucid account of the socio-cultural context behind the rising rates of prescription of psycho-stimulants for children. Read more…

Gordon Brown’s recent speech on the limits of market mechanisms did not go quite far enough, argues Margaret CookWhen great men make great speeches it has been remarked that the content is often not as impressive in the reading as in the hearing. Read more…

Proposals to deregulate the market for community pharmacy may end up cutting services patients need, says Richard LewisTo the casual observer, the Office of Fair Trading seems to have it in for community pharmacists. Read more…

Most health research is driven by commercial interests, leading to significant gaps in healthcare understanding, a report from the King’s Fund thinktank concludes. Read more…

Thousands of gene patents have been issued – yet in most cases they are not inventions, and patenting harms the public interest, warns Sue MayerFor some years a fierce argument has been raging over whether genes should be patentable. Read more…

Many deaths in developing countries could be avoided if essential drug prices were lowered. Ken Bluestone explains how pharmaceutical companies are being urged to take their social responsibilities seriouslyWhy not lower drugs prices systematically for developing countries? Read more…

Too many people who visit their GP with mental health problems are being offered drugs as the only option, according to the mental health charity Mind which has launched a campaign for more choice. Read more…